SRTS — Sensus Healthcare Income Statement
0.000.00%
Last trade - 00:00- $52.61m
- $30.45m
- $41.81m
Annual income statement for Sensus Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9.58 | 27 | 44.5 | 24.4 | 41.8 |
| Cost of Revenue | |||||
| Gross Profit | 5.25 | 17 | 29.6 | 14.1 | 24.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 16.5 | 22.9 | 29.7 | 24.8 | 33.7 |
| Operating Profit | -6.89 | 4.12 | 14.8 | -0.382 | 8.09 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -6.84 | 4.12 | 28 | 0.652 | 9.02 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.84 | 4.12 | 24.2 | 0.485 | 6.65 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.84 | 4.12 | 24.2 | 0.485 | 6.65 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.84 | 4.12 | 24.2 | 0.485 | 6.65 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.498 | 0.258 | 0.793 | 0.028 | 0.406 |